Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
Described as a "don't eat me" signal, CD47 becomes a vital immune checkpoint in cancer. Its interaction with signal regulatory protein alpha (SIRPα) prevents macrophage phagocytosis. In recent years, a growing body of evidences have unveiled that CD47-based combination therapy exhibit...
Saved in:
Main Authors: | Zi-Han Ye (Author), Wei-Bang Yu (Author), Mu-Yang Huang (Author), Jun Chen (Author), Jin-Jian Lu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer
by: Chen Feng, et al.
Published: (2023) -
"Biomaterial engineering:" The backbone for regeneration
by: Praveen Bhasker Kudva
Published: (2016) -
Significance of CD47 expression in endometrial carcinoma
by: Nurhan Sahin, et al.
Published: (2022) -
Is Hygiene Still the Backbone of Your Practice?
by: Rachel Wall
Published: (2023) -
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
by: Restelli U, et al.
Published: (2017)